Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Discovery and development of targeted biotherapeutics to treat serious diseases and conditions52K100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States570K100.00%